Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivo (Q35946392)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivo |
scientific article |
Statements
Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivo (English)
Valerie N Barton
Nicholas C D'Amato
Michael A Gordon
Hanne T Lind
Nicole S Spoelstra
Beatrice L Babbs
Anthony Elias
Paul Jedlicka
Jennifer K Richer
23 February 2015
1 reference